QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2

Abdullahi Bello Umar, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba

Heliyon · 2020 · 40 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

) the known inhibitor of the target (V600E-BRAF). These findings may be very helpful in early anti-cancer drug development.

References

25